BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10779466)

  • 1. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
    Tanner FC; Meier P; Greutert H; Champion C; Nabel EG; Lüscher TF
    Circulation; 2000 Apr; 101(16):1982-9. PubMed ID: 10779466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.
    Kibbe MR; Li J; Nie S; Watkins SC; Lizonova A; Kovesdi I; Simmons RL; Billiar TR; Tzeng E
    J Vasc Surg; 2000 Jun; 31(6):1214-28. PubMed ID: 10842159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells.
    Sharma RV; Tan E; Fang S; Gurjar MV; Bhalla RC
    Am J Physiol; 1999 May; 276(5):H1450-9. PubMed ID: 10330227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis.
    Sato J; Nair K; Hiddinga J; Eberhardt NL; Fitzpatrick LA; Katusic ZS; O'Brien T
    Cardiovasc Res; 2000 Sep; 47(4):697-706. PubMed ID: 10974218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.
    Fukumoto S; Koyama H; Hosoi M; Yamakawa K; Tanaka S; Morii H; Nishizawa Y
    Circ Res; 1999 Nov; 85(11):985-91. PubMed ID: 10571528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cdk2 activity in endothelial cells that are inhibited from growth by cell contact.
    Chen D; Walsh K; Wang J
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):629-35. PubMed ID: 10712384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
    Naderi S; Gützkow KB; Christoffersen J; Smeland EB; Blomhoff HK
    Eur J Immunol; 2000 Jun; 30(6):1757-68. PubMed ID: 10898514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ; Weiss RH
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
    Hayashi S; Morishita R; Matsushita H; Nakagami H; Taniyama Y; Nakamura T; Aoki M; Yamamoto K; Higaki J; Ogihara T
    Hypertension; 2000 Jan; 35(1 Pt 2):237-43. PubMed ID: 10642304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol inhibits human aortic smooth muscle cell growth: effects on cell cycle regulatory proteins.
    André DE; Arnet U; Yang Z; Lüscher TF
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):845-8. PubMed ID: 10836716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
    Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules.
    Hsu SL; Hsieh YC; Hsieh WC; Chou CJ
    Eur J Pharmacol; 2001 Aug; 425(3):165-71. PubMed ID: 11513834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
    Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
    Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
    Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.
    Yang Z; Krasnici N; Lüscher TF
    Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.